Drug Retailers

CVS Health Corp confirms FY, Q1 2016 EPS guidance

CVS Health Corp:Confirmed its previous guidance for FY 2016 and Q1 2016.Expects to deliver adjusted EPS of $5.73 to $5.88 and GAAP diluted earnings per share from continuing operations of $5.28 to $5.43 in FY 2016.Confirmed its Q1 2016 adjusted EPS guidance of $1.14 to $1.17 and GAAP diluted...

Tuesday, 9 Feb 2016 06:51am EST

Vital Ksk Holding raises consolidated full-year outlook for FY 2016

Vital Ksk Holding Inc:Says the company increased the consolidated full-year outlook for revenue to 613,500 mln yen from 600,000 mln yen, for the fiscal year ending March 31, 2016.Operating profit forecast increased to 5,000 mln yen from 3,000 mln yen.Ordinary profit forecast increased to 8,700 mln...

Tuesday, 9 Feb 2016 01:00am EST

Prestige Brands Holdings, Inc completes acquisition of DenTek Holdings Inc

Prestige Brands Holdings, Inc:Completes acquisition of DenTek Holdings Inc.

Monday, 8 Feb 2016 04:30pm EST

Oriola-KD gives guidance on FY 2016, proposes dividend for FY 2015

Oriola-KD Oyj:Estimates its FY 2016 net sales to remain at FY 2015 level on constant currency basis​.FY ‍2016 adjusted operating profit is estimated to remain at FY 2015 level or to increase, on a constant currency basis​.‍Board proposes to annual general meeting that a dividend of 0.13 euros per...

Friday, 5 Feb 2016 01:31am EST

Restructuring & Reorganization

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider : Banorte-Ixe
$10.00
Provider : Banorte-Ixe
$10.00
Provider : Banorte-Ixe
$10.00
Provider : Banorte-Ixe
$10.00
Provider : Banorte-Ixe
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.